Is it appropriate for the FDA to approve drugs for race-specific indications, as it did with BiDil?

Related Book For  answer-question

Smith and Roberson Business Law

ISBN: 978-0538473637

15th Edition

Authors: Richard A. Mann, Barry S. Roberts

Posted Date: